financetom
Business
financetom
/
Business
/
Exclusive-US Republican senator calls for DOJ and Homeland Security to investigate Shein, Temu for counterfeiting
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Exclusive-US Republican senator calls for DOJ and Homeland Security to investigate Shein, Temu for counterfeiting
Mar 10, 2026 9:09 PM

NEW YORK, Dec 1 (Reuters) - U.S. Republican Senator Tom Cotton of Arkansas sent a letter to Attorney General Pam Bondi on Monday calling for the U.S. departments of Justice and Homeland Security to investigate online retailers Shein and Temu, which ship most of their merchandise from China, for wide-scale intellectual property theft and counterfeiting. 

The letter, which was seen by Reuters, adds to the increased scrutiny of Shein and Temu, which both sell $20 shirts and $10 accessories, following the end of a U.S. trade exemption that helped both companies gain popularity in the region. Shein is privately held and Temu is owned by PDD Holdings ( PDD ).

Shein did not immediately respond to a request for comment.  A Temu spokesperson said a comment was not immediately available outside of normal business hours.

Shein has previously said that it requires its suppliers to certify that their products do not infringe on a brand's intellectual property and that they are not counterfeit. The company has a team that ensures its sellers comply with the policy and takes swift action if they are not in compliance, a spokesperson previously said. 

The ending of the de minimis exemption, which allowed packages shipped directly to shoppers valued at under $800 to enter the U.S. duty-free, has "forced Shein and Temu to change their business model," Cotton said in the letter.  

"These companies now stock massive inventories in U.S. warehouses and distribution centers. Their goods are no longer slipping through ports," Cotton said. "They are sitting on American soil under U.S. jurisdiction."

Texas Attorney General Ken Paxton said on Monday he is investigating whether Shein violated state law related to unethical labor practices and the sale of unsafe consumer products. France last week asked a Paris judge to suspend Shein in the country for three months over sales of childlike sex dolls and banned weapons.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sanofi Q1 Earnings Fall, Net Sales Climb
Sanofi Q1 Earnings Fall, Net Sales Climb
Apr 25, 2024
07:01 AM EDT, 04/25/2024 (MT Newswires) -- Sanofi ( SNY ) reported Q1 non-IFRS business earnings Thursday of 1.78 euros ($1.90) per share, down from 2.16 euros a year earlier. An analyst polled by Capital IQ expected 1.71 euros. Net sales for the quarter were 10.46 million euros, up from 10.22 million euros a year earlier. Analysts polled by Capital...
Alphabet Tends to Reverse or Narrow Post-Market Earnings Moves in Follow-On Regular Session
Alphabet Tends to Reverse or Narrow Post-Market Earnings Moves in Follow-On Regular Session
Apr 25, 2024
07:00 AM EDT, 04/25/2024 (MT Newswires) -- Alphabet (GOOGL, GOOG) is due with its Q1 results in the after-hours today. Analysts polled by Capital IQ expect the company to post a profit of $1.50 per share on revenue of $78.7 billion. GOOGL has recorded an earnings-driven after-hours decline in 32 of the last 78 quarters we've tracked, and in 14...
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
Apr 25, 2024
April 25 (Reuters) - Merck & Co ( MRK ) on Thursday raised its annual profit and revenue forecast on the back of strong sales for its blockbuster cancer drug Keytruda and human papillomavirus (HPV) vaccine Gardasil. The New Jersey-based drugmaker said it expected earnings of $8.53 and $8.65 per share, up from its previous prediction of $8.44 to $8.59,...
Merck Non-GAAP Earnings, Sales Rise; 2024 Guidance Raised
Merck Non-GAAP Earnings, Sales Rise; 2024 Guidance Raised
Apr 25, 2024
07:00 AM EDT, 04/25/2024 (MT Newswires) -- Merck ( MRK ) reported Q1 non-GAAP earnings Thursday of $2.07 per share, up from $1.40 a year ago. Analysts polled by Capital IQ expected $1.92. Sales for the quarter ended March 31 were $15.78 billion, up from $14.49 billion a year earlier. Analysts surveyed by Capital IQ expected $15.20 billion. For 2024,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved